Accepted at 3:17 p.m. Oct, 31, 2023 by Joe
Author: gorha044
Related Note: 1541800160363 1
Rationale for change

Clarity. Also depending on the severity, other things are first line, rather than medications.

Text Text
Extra
- UWorld confirms that dopamine modulators such as VMAT-2 inhibitors (tetrabenazine) and atypical antipsychotics are best practice

- When choosing between the two, VMAT-2 inhibitors are preferred due to the lower side effect profile

Others: guanfacine, clonidine
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Review Clonidine & Guanfacine


Physeo

Bootcamp
Watch associated Bootcamp video - Developmental Disorders : Isolating Developmental Disorders
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step2_v12::Original_decks::Dorian::fam::amboss #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::16_Atypical_Antipsychotics #AK_Step2_v12::#SketchyPsych::07_Child_&_Adolescent_Psychiatry::05_Tic_Disorders::01_Tourette_Syndrome #AK_Step2_v12::#OME::04_Psychiatry::12_Peds_Neurodevelopmental #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step2_v12::#AMBOSS::XH09Kh #AK_Step1_v12::#OME_banner #AK_Step2_v12::Original_decks::Dorian::psych::emma #AK_Step2_v12::!Shelf::FM::no_dupes::only_step2 #AK_Step1_v12::#Pixorize::03_Pharmacology::23_Sympathomimetics_&_Sympatholytics_(New)::06_Clonidine_Guanfacine #AK_Step1_v12::#Bootcamp::Psychiatry::02_Developmental_Disorders::05_Isolating_Developmental_Disorders #AK_Step1_v12::#B&B::17_Psych::02_Pathology::03_Childhood_Disorders #AK_Step2_v12::!Shelf::FM::no_dupes #AK_Step2_v12::$AnKingUpdates::$Errata::v11 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#UWorld::Step::20778 #AK_Step2_v12::!Shelf::#Cards_AnKing_Did::4fm #AK_Step2_v12::#UWorld::COMLEX::104873 !AK_UpdateTags::Step2decks::Cheesy-Dorian-(M3)::Psychiatry::2-Emma-Holiday-Review+HY-Stuff #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::15_Typical_Antipsychotics #AK_Step2_v12::#B&B::12_Pediatrics::03_Other::03_Child_Psychiatry #AK_Step2_v12::#Subjects::Psychiatry::12_Childhood_&_Early_Onset_Disorders::Tourettes #AK_Step2_v12::#Subjects::Psychiatry::12_Childhood_&_Early_Onset_Disorders::Tourettes::Management #AK_Step1_v12::#OME_banner::Clinical::12_Psychiatry::12_Peds_Neurodevelopmental #AK_Step2_v12::#Resources_by_rotation::Psych::emma #AK_Step1_v12::#Pixorize::03_Pharmacology::04_Sympathomimetics_&_Sympatholytics::10_Clonidine_(and_Guanfacine)